(Q40163796)

English

Effect of a cyclooxygenase-2 inhibitor on interleukin-1beta-stimulated activation of the transcription factor nuclear factor-kappa B in human gingival fibroblasts

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Effect of a cyclooxygenase-2 inhibitor on interleukin-1beta-stimulated activation of the transcription factor nuclear factor-kappa B in human gingival fibroblasts (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

author name string

David A Tipton

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Denise C Gay

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Vaughn A DeCoster

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Journal of Periodontology

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

78

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

542-549

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

The role of inflammatory mediators in the pathogenesis of periodontal disease

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Marginal periodontitis and cytokines: a review of the literature

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Role of cytokines and inflammatory mediators in tissue destruction

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Effect of smoking on gingival crevicular fluid cytokine profile during experimental gingivitis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

The interleukin-1 genotype as a severity factor in adult periodontal disease

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Interleukin (IL)-1 and Porphyromonas gingivalis lipopolysaccharide stimulation of IL-6 production by fibroblasts derived from healthy or periodontally diseased human gingival tissue

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Cyclooxygenase 2 and the kidney

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Modulation of host PGE2 secretion as a determinant of periodontal disease expression

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Periodontal diseases: pathogenesis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Interleukin-1 signal transduction

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Regulation of macrophage eicosanoid generation is dependent on nuclear factor kappaB.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

NS-398 treatment after trauma modifies NF-kappaB activation and improves survival

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Activation of NFkappaB is necessary for IL-1beta-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

COX-2 inhibitors and risk of heart failure

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Renal failure associated with the use of celecoxib and rofecoxib

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2007.060250

21 January 2018

Identifiers

10.1902/JOP.2007.060250

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40163796&oldid=1887809669"